Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com. To view our community guidelines, click here: https://bit.ly/3BYPnpK
View Top Employees from Dyne Therapeutics| Website | http://www.dyne-tx.com |
| Employees | 161 (134 on RocketReach) |
| Founded | 2018 |
| Address | 1560 Trapelo Rd, Waltham, Massachusetts 02451, US |
| Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care, Medical, Pharmaceutical |
| Keywords | Rare Genetic Diseases, Duchenne Muscular Dystrophy |
Looking for a particular Dyne Therapeutics employee's phone or email?
Dyne Therapeutics Questions
Josh Brumm is the President and Chief Executive Officer of Dyne Therapeutics.
134 people are employed at Dyne Therapeutics.
Dyne Therapeutics is based in Waltham, Massachusetts.
Top Dyne Therapeutics Employees
-
5+4
-
5+5+
-
55+
-
5+5+
-
55
-
View
Soma Ray
Vice President, Head of Translational Biomarkers at Dyne Therapeutics
Boston, Massachusetts, United States32 -
ViewBrian Newkirk
VP, Program Team Leader and Head of New Product Planning at Dyne Therapeutics
Cambridge, Massachusetts, United States52 -
35+
-
25+
Related Companies
